1. Home
  2. ASMB vs TRVG Comparison

ASMB vs TRVG Comparison

Compare ASMB & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • TRVG
  • Stock Information
  • Founded
  • ASMB 2005
  • TRVG 2005
  • Country
  • ASMB United States
  • TRVG Germany
  • Employees
  • ASMB N/A
  • TRVG N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • ASMB Health Care
  • TRVG Technology
  • Exchange
  • ASMB Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • ASMB 100.5M
  • TRVG 116.4M
  • IPO Year
  • ASMB 2010
  • TRVG N/A
  • Fundamental
  • Price
  • ASMB $14.72
  • TRVG $1.68
  • Analyst Decision
  • ASMB Buy
  • TRVG Buy
  • Analyst Count
  • ASMB 2
  • TRVG 4
  • Target Price
  • ASMB $35.00
  • TRVG $2.55
  • AVG Volume (30 Days)
  • ASMB 23.4K
  • TRVG 47.7K
  • Earning Date
  • ASMB 11-07-2024
  • TRVG 11-05-2024
  • Dividend Yield
  • ASMB N/A
  • TRVG N/A
  • EPS Growth
  • ASMB N/A
  • TRVG N/A
  • EPS
  • ASMB N/A
  • TRVG N/A
  • Revenue
  • ASMB $28,326,000.00
  • TRVG $510,563,239.00
  • Revenue This Year
  • ASMB $267.67
  • TRVG N/A
  • Revenue Next Year
  • ASMB $46.15
  • TRVG $5.96
  • P/E Ratio
  • ASMB N/A
  • TRVG N/A
  • Revenue Growth
  • ASMB N/A
  • TRVG N/A
  • 52 Week Low
  • ASMB $8.16
  • TRVG $1.60
  • 52 Week High
  • ASMB $19.93
  • TRVG $3.29
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 35.66
  • TRVG 48.08
  • Support Level
  • ASMB $15.92
  • TRVG $1.66
  • Resistance Level
  • ASMB $17.48
  • TRVG $1.69
  • Average True Range (ATR)
  • ASMB 1.07
  • TRVG 0.05
  • MACD
  • ASMB -0.25
  • TRVG 0.00
  • Stochastic Oscillator
  • ASMB 28.54
  • TRVG 21.28

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: